JAZZ vs TRN · P/E 1988, rev $2.28B vs P/E 16, rev $977.1M
Jazz Pharmaceuticals PLC (JAZZ) versus Trinity Industries Inc (TRN) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Trinity Industries Inc (TRN) is a railroads company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TRN revenue for 2026-06-30 was $977.1M. Net income was $122.5M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. TRN currently screens at market cap $2.37B and trailing P/E 16.4.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TRN currently screens at market cap $2.37B and trailing P/E 16.4.
Not investment advice. Open the JAZZ and TRN stock pages for the full models.
Not investment advice.